The NENC Integrated Care System now has one governance procedure through the ICB Medicines Sub-Committee. This is supported by Northern Treatment Advisory Group (NTAG) and its subgroups. Until guidance can be reviewed by the ICB Medicines Sub-Committee and its sub-groups all guidance and agreements previously approved by the predecessor three Area Prescribing Committees (APCs) of County Durham & Tees Valley; North of Tyne, Gateshead & North Cumbria; and South Tyneside & Sunderland are still valid whilst within their review date. Clinicians referring to this guidance after any expiry date should exercise caution. ICB approved prescribing guidance and agreements will be hosted on the NTAG website moving forward and this is available publicly at https://ntag.nhs.uk/ .
APC guidance has been grouped according to BNF chapter.
Guidance includes
– Shared care guidance
– Clinical guidelines
– Information sheets – to help ongoing care in primary care following specialist initiation/recommendation.
Gastro-Intestinal System
Abnormal Liver Blood Test guidelines NENC Hepatology Network v2.2
Bariatric GP guidance – Extended to July 2024
Constipation guideline January 2023
Trans Anal Irrigation guidelines March 2023
Cardiovascular System
NENC Amiodarone shared care guideline
Angina Guideline January 2023
Dronedarone shared care protocol – see NTAG
NEELI Clinical Guidelines – See NTAG
North East Guideline For Use Of Sodium Glucose Co transporter 2 Inhibitors (SGLT2i) see NTAG
Respiratory System
COPD Management Guidelines v2.2 Jan 2023
Asthma in children – Full Guideline January 2023
Asthma in children – Summary Guideline January 2023
Central Nervous system
Agomelatine Primary Care Information Sheet 5.2 June 2023
Dementia medicines leaflet January 2023
Adult ADHD Shared Care (extended March 2024)
Children’s ADHD Shared care June 2023
Antipsychotic Leaflet update – August 2022
Dexamfetamine-for-Narcolepsy-SCG (extended to Feb 2024)
Sativex for the treatment of spasticity in multiple sclerosis – See NTAG
Apomorphine-shared-care-agreement-V1.1
Methylphenidate Narcolepsy SCG March 2023
Regional Headache Guideline March 2022
Ketamine-in-Palliative-Care-pain-2020-v1.0 FILLABLE
Lithium-shared-care-NoTGNC-June-2022 v1.0
Methylphenidate-secondary-to-brain-injury-Sept-21 v1.0
Melatonin for the management of Sleep Wake Disorders in Children and Young People SCG amended March 2023
Melatonin Deprescribing Guideline March 2022
Vigabatrin SCG January 2023
Infections and antibiotics
Antibiotic and Diagnostic quick reference tools
Nebulised Gentamicin Information for Primary Care March 23
Endocrine System
Thyroid Gudelines (TRAMP2) June 2018
Northern Region Gender Dysphoria Service – General Guidelines for the use of Hormone Treatment in Gender Dysphoria
NENC ICB – Management of Menopause
Diabetes
Blood-glucose-monitoring-guideline-v2.1
North East Guideline For Use Of Sodium Glucose Co transporter 2 Inhibitors (SGLT2i) – See NTAG
NENC Medication Management for Type 2 Diabetes in Adults Guidelines
Genito-Urinary System
Erectile Dysfunction Guidelines for the investigation and management of men with ED Updated August 2022
Non Surgical Management of Overactive Bladder (OAB) Pathway February 2021
Urology Guidelines March 2023
Methylphenidate for giggle incontinence – Children Updated March 2023
North of Tyne, Gateshead and North Cumbria Catheter Care Product Formulary 2023
Renal Disease
Immunosuppressive-Treatment-for-Paediatric-Nephrotic-Syndrome-SCG v1.0
North-East Guideline For Use Of Sodium Glucose Co-transporter 2 Inhibitors (SGLT2i) – See NTAG
Malignant Disease and Immunosuppression
NoT G Monitoring of IMDs Updated Sept 2022
HCQ-Shared-care-guidance-v.5-Oct-2022-Final
Immunosuppressive-treatment-following-liver-transplants-SCG-June-21-update-Final
Lanreotide and Octreotide July 2019 v2.0
Immunosuppression-following-Paediatric-renal-transplantation-SCG-March 23
Tocilizumab monitoring SCG January 2023
NECN Palliative and End of life Symptom Control Guidelines 2021 (Fifth edition)
Immunosuppression following adult renal transplant
azathioprine-shared-care-agreement-2021-final
ciclosporin-shared-care-agreement-2021-final
mmf-mycophenolic-acid-shared-care-agreement-2021-final
prednisolone-shared-care-agreement-2021-final
sirolimus-shared-care-agreement-2021-final
tacrolimus-shared-care-agreement-2021-final
Immunosuppressive-treatment-following-liver-transplants-SCG-June-21-update-Final
Nutrition and Blood
erythropoietin-for-CKD-SCG – January 2023
cinacalcet in primary hyperparathyroidism March 2023
NoT CMA and lactose Intolerance Guidelines March 2023
Vitamin D Quick reference guide v3.0
Gluten free guidelines Updated Nov 2022
Oral Nutritional Support guidance and formulary FINAL v1.0 Jan 2021
Preterm Infant feeding prescribing guideline 2021-final
Faltering Growth February 2021 final
Musculoskeletal and Joint Diseases
Denosumab information sheet – Dec 2021
Osteoporosis (ext June 2022)
Ear, Eyes, Nose and Throat
Newcastle upon Tyne ENT GP Referral Guidelines
Ophthalmology Referral Guidelines January 2023
Other Guidance
Seven-day-Rx-and-MCAs v2.4
Stoma-Prescribing-Guidelines Sept 2020
Swallowing-difficulties v2.0
Third party ordering January 2023
